HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

Por Van Gorp, T, Cadron, I, Despierre, E, Daemen, A, Leunen, K, Amant, F, Timmerman, D, De Moor, B, Vergote, I
Publicado em 2011

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

Por Hofstetter, G, Berger, A, Schuster, E, Wolf, A, Hager, G, Vergote, I, Cadron, I, Sehouli, J, Braicu, E I, Mahner, S, Speiser, P, Marth, C, Zeimet, A G, Ulmer, H, Zeillinger, R, Concin, N
Publicado em 2011